News and Trends 4 Apr 2025 Developing drugs from outer space: Exobiosphere raises €2 million Find out about how biotech is done in space through the example of Exobiosphere and its €2 million seed round. April 4, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Mar 2025 12 AI drug discovery companies you should know about Take a look at 12 of the top AI drug discovery companies around today, using their technology to speed up the drug discovery process. March 27, 2025 - 19 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Interview 20 Mar 2025 AI meets biotech: Bullfrog AI’s CEO on the TechBio boom Find out about how TechBios are changing the industry by leveraging AI and partnering with biotech in our interview with Bullfrog AI’s CEO. March 20, 2025 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 7 Mar 2025[Rebroadcast] How AI immune system mapping can boost drug discovery Learn about the data gap in drug discovery and how machine learning (ML) can solve it in our talk with Noam Solomon, CEO and co-founder of Immunai. March 7, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Reports Produced by Inpart 3 Mar 2025R&D trends: Biotech assets & discovery platforms Inpart’s latest report provides access to the most promising biotech assets and discovery platforms, shedding light on the latest trends in biotech R&D. March 3, 2025 Share WhatsApp Twitter Linkedin Email Produced by Inpart
Best in Biotech 14 Jan 2025 Singapore’s biotech scene: 7 companies leading the way in 2025 Discover seven of the top biotech companies in Singapore – a country that set out to become a global biotech hub just over 20 years ago. January 14, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 22 Nov 2024 Can AlphaFold3’s open-source platform revolutionize the way we discover drugs? Find out how Google DeepMind’s AlphaFold3 platform could help scientists revolutionize the field of drug discovery. November 22, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 18 Nov 2024 What is Abcam’s founder, Jonathan Milner, up to? Since Abcam was acquired in December 2023, its founder, Jonathan Milner has been very active. Delve into his investment strategy. November 18, 2024 - 17 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 1 Nov 2024 Can AI cure Alzheimer’s disease? A couple of weeks back, we took a look at how artificial intelligence (AI) has had a transformative impact on cancer research. Today, we take a look at how AI tools help tackle another formidable challenge of modern biotech, Alzheimer’s disease. “Alzheimer’s is an incredibly complex disease with numerous factors at play. You have the […] November 1, 2024 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 18 Oct 2024 The AI boom in cancer: Game-changer or just hype? Is AI just hype or a game-changer? Delve into AI’s contribution to oncology, from diagnostics to drug discovery and personalized treatment. October 18, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Oct 2024 Six biomimicry biotech companies harnessing nature’s wisdom to develop breakthrough drug candidates Find out more about six biomimicry companies harnessing nature’s wisdom to create drug candidates for the benefit of human health. October 14, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Sponsored by Indivumed Therapeutics 8 Oct 2024 How an innovative, data-driven approach is revolutionizing drug discovery for solid tumors Learn how cancer tissue biobanks and insights into solid tumor heterogeneity are transforming drug discovery and paving the way for innovative treatments. October 8, 2024 - 6 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email